Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Semin Arthritis Rheum.

Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M, Erra A, Serrat M, Espartal E, Antón S, Añez GA, Caparrós-Ruiz R, Pluma A, Trallero-Araguás E, Barceló-Bru M, Almirall M, De Agustín JJ, Segura JL, Julià A, Marsal S

doi: 10.1016/j.semarthrit.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

Ann Rheum Dis.

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS

doi: 10.1136/annrheumdis-2020-217888.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Ann Rheum Dis.

Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R, Gonzalez-Gay MA, Martinez-Lopez D, Castrejón I, Alvaro-Gracia JM, Fernández Fernández D, Mera-Varela A, Manrique-Arija S, Mena Vázquez N, Fernandez-Nebro A, RIER Investigators Group., RIER investigators group

doi: 10.1136/annrheumdis-2020-218296.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

Ann Rheum Dis.

Ye C, Cai S, Shen G, Guan H, Zhou L, Hu Y, Tu W, Chen Y, Yu Y, Wu X, Chen Y, Zhong J, Dong L

doi: 10.1136/annrheumdis-2020-217627.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Ann Rheum Dis.

Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC, COVID-19 Global Rheumatology Alliance.

doi: 10.1136/annrheumdis-2020-217871.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 in rheumatic disease patients on immunosuppressive agents

Semin Arthritis Rheum.

Sharmeen S, Elghawy A, Zarlasht F, Yao QP

doi: 10.1016/j.semarthrit.2020.05.010.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis

J Rheumatol.

Favalli EG, Agape E, Caporali R

doi: 10.3899/jrheum.200507.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Perspectives of patients with rheumatic diseases in the early phase of COVID-19

Arthritis Care Res (Hoboken).

Antony A, Connelly K, De Silva T, Eades L, Tillett W, Ayoub S, Morand E

doi: 10.1002/acr.24347.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic

Arthritis Rheumatol.

Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG

doi: 10.1002/art.41301.

Related content

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

COVID-19 in rheumatic disease patients on immunosuppressive agents

Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis

Perspectives of patients with rheumatic diseases in the early phase of COVID-19

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic